Central nervous system involvement of systemic ALK-positive histiocytosis with KIF5B-ALK fusion
ALK-positive histiocytosis is an emerging histiocytic entity that can involve a single organ or multiple organs. This disease frequently involves the central nervous system, and the importance of immunohistochemical and genetic analyses is emphasized for the accurate diagnosis of this rare entity. H...
Main Authors: | Yuzuna Aoki, MD, Masayuki Maeda, MD, PhD, Seiya Kishi, MD, Ryota Kogue, MD, PhD, Fumine Tanaka, MD, Maki Umino, MD, PhD, Mami Takeoka, MD, Ryo Hanaki, MD, PhD, Junya Hirayama, MD, PhD, Hiroto Yuasa, MD, Hiroshi Imai, MD, PhD, Masahiro Hirayama, MD, PhD, Hajime Sakuma, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | Radiology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1930043322006173 |
Similar Items
-
Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement—Combination of EGFR Tyrosine Kinase Inhibitors and ALK Inhibitors
by: Ming-Hung Huang, PhD, et al.
Published: (2022-11-01) -
First Report of Management of Sequential Small Cell Transformation and ALK I1171T Mutation as Resistance Mechanisms in a Patient With ALK-EML4 Fused Non–Small Cell Lung Adenocarcinoma With a Novel Combination of Temozolomide and Lorlatinib: A Case Report
by: Umair Majeed, MD, et al.
Published: (2023-07-01) -
Catalog of 5’ Fusion Partners in ALK-positive NSCLC Circa 2020
by: Sai-Hong Ignatius Ou, MD, PhD, et al.
Published: (2020-03-01) -
ALK Deletion Exons 2 to 19: Case Report of a Rare ALK Inhibitor–Responsive Lung Cancer Driver Oncogene
by: Zachary R. Schoepflin, MD, et al.
Published: (2023-04-01) -
A Case of Lung Adenocarcinoma Harboring a Rare LOC285000-ALK-NCK2 Gene Fusion Identified by Next-Generation Sequencing With Long-Term Response to Crizotinib
by: Min Zhang, MBBS, et al.
Published: (2021-02-01)